Showing results (201-210 of 286) with videos related to

Sort By:
Pageof 29
Communications Medicine|February 26, 2024
Humoral and cellular immune responses to COVID-19 mRNA vaccines in immunosuppressed liver transplant recipientsTakuto Nogimori, Yuta Nagatsuka, Shogo Kobayashi, et al.
Journal of Diabetes Research|May 27, 2024
Skeletal Myoblast Cells Enhance the Function of Transplanted Islets in Diabetic MiceTakeshi Kado, Yoshito Tomimaru, Shogo Kobayashi, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2023
Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinomaHidemi Nishi, Kunihito Gotoh, Yoshito Tomimaru, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 12, 2020
[A Resected Case of Hemorrhagic Hepatic Cyst Difficult to Differentiate from Mucinous Cystic Neoplasm of the Liver]Sung Ae Park, Yoshito Tomimaru, Kozo Noguchi, et al.
Plos One|January 5, 2016
A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract CancerTakuya Sakamoto, Shogo Kobayashi, Daisaku Yamada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 12, 2020
[Surgical Outcomes of Laparoscopic Repeat Hepatectomy at Our Institution]Koki Kaketaka, Kozo Noguchi, Yoshito Tomimaru, et al.
Cancer Letters|December 11, 2020
Inhibition of glycolytic activator PFKFB3 suppresses tumor growth and induces tumor vessel normalization in hepatocellular carcinomaKenichi Matsumoto, Takehiro Noda, Shogo Kobayashi, et al.
Cancer Science|March 15, 2022
Tumor endothelial cell-induced CD8<sup>+</sup> T-cell exhaustion via GPNMB in hepatocellular carcinomaYoshihiro Sakano, Takehiro Noda, Shogo Kobayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[Case of Adenocarcinoma with Neuroendocrine Carcinoma Component in the Gallbladder]Yu Takeda, Kozo Noguchi, Yoshito Tomimaru, et al.
Journal of Cancer Research and Clinical Oncology|June 17, 2023
SPARC accelerates biliary tract cancer progression through CTGF-mediated tumor-stroma interactions: SPARC as a prognostic marker of survival after neoadjuvant therapyHirotoshi Takayama, Shogo Kobayashi, Kunihito Gotoh, et al.
Pageof 29